The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma

Qian He,Shu-Qun Zhang,Yong-Lie Chu,Xiao-Li Jia,Xiang-Ling Wang
DOI: https://doi.org/10.1007/s11033-008-9249-9
IF: 2.7422
2008-01-01
Molecular Biology Reports
Abstract:Breast carcinoma (BC) is a prevalent malignant tumour occurring in women. Many studies have indicated the role of human papilloma virus type 16 (HPV16) in the pathogenesis of BC; however, the correlations of HPV16 infection with the clinicopathologic features of BC and the expressions of c-erbB-2 and bcl-2 have not yet been elucidated. In this study, HPV16 was detected by amplifying the HPV16 E6 gene by the polymerase chain reaction method, and the expressions of c-erbB-2 and bcl-2 in 40 BCs and 20 normal breast tissue samples, obtained from Shaanxi Province, were examined using the streptavidin-peroxidase method with monoclonal antibodies specific to c-erbB-2 and bcl-2. The infection rate of HPV16 E6 and the positive expression rate of c-erbB-2 were significantly higher in the BCs than in the normal tissues (HPV16 E6: 60% vs. 5%; c-erbB-2: 42.5% vs. 5%, P < 0.05). However, the positive expression rate of bcl-2 was significantly lower in the BCs than in the normal tissues (67.5% vs. 95%, P < 0.05). The infection rate of HPV16 did not correlate with any of the pathological features observed ( P > 0.05). HPV16 infection correlated with bcl-2 expression ( P = 0.015) but not with c-erbB-2 expression ( P = 0.747) in the BCs. Interestingly, HPV16 infection correlated with bcl-2 expression in grade I BCs ( P = 0.018) but not in grade II–III BCs ( P = 0.633). Our data suggest that HPV16 infection is correlated with bcl-2 expression in BCs.
What problem does this paper attempt to address?